Related Experiment Video

Updated: Apr 18, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

8.5K

Signaling pathway STAT1 is strongly activated by IFN-β in the pathogenesis of osteoporosis

Claudine Seeliger1, Lilianna Schyschka2, Zienab Kronbach3

  • 1Department of experimental Trauma Surgery, Klinikum rechts der Isar, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany. seeliger@uchir.me.tum.de.

European Journal of Medical Research
|January 8, 2015
PubMed
Abstract

Insights

Interferon-beta (IFN-β) inhibits osteoclast activity in osteoporosis by activating the STAT1 pathway. This study confirms IFN-β

Area of Science:

  • Bone Biology and Metabolism
  • Immunology and Inflammation
  • Cell Signaling Pathways

Background:

  • Osteoporosis pathogenesis remains incompletely understood, despite extensive research.
  • The interferon-beta (IFN-β)/STAT1 pathway is implicated in bone metabolism.
  • Previous studies suggest IFN-β inhibits osteoclastogenesis and STAT1/2 influences osteoblasts, but data in patient-derived cells are lacking.

Purpose of the Study:

  • To investigate the role of the IFN-β/STAT1 pathway in osteoblasts and osteoclasts from osteoporotic and non-osteoporotic patients.
  • To analyze the effects of IFN-β stimulation on cell viability, activity, gene expression, and key protein levels.

Main Methods:

  • Osteoblasts were isolated from 12 osteoporotic and 11 non-osteoporotic patients.
  • Monocytes were differentiated into osteoclasts.
  • Cells were stimulated with IFN-β (20 and 100 ng/mL) and analyzed for viability, activity, gene expression, and proteins (Fra1, SOCS1, STAT1, p-STAT1, TRAF6).

Main Results:

  • IFN-β stimulation did not affect osteoblast viability, activity, or gene expression.
  • In osteoporotic osteoclasts, IFN-β significantly inhibited basal osteoclastic activity.
  • IFN-β increased STAT1 activation and p-STAT1 levels in osteoclasts from both patient groups, with no significant effect on osteoblasts.

Conclusions:

  • IFN-β is a key mediator in osteoporosis pathogenesis, primarily by inhibiting osteoclasts and activating STAT1.
  • The study confirms the role of the IFN-β/STAT1 pathway in patient-derived osteoporotic and non-osteoporotic cells.
  • IFN-β demonstrates potent inhibitory effects on osteoclastogenesis, particularly in osteoporotic cells, without negatively impacting osteoblast activity.

More Related Videos

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.2K
Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes11:52

Differentiation of Functional Osteoclasts from Human Peripheral Blood CD14+ Monocytes

Published on: January 27, 2023

4.9K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.9K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.3K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.9K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K